News Detail

Deebio successfully passed the official GMP certification of Japan PMDA!

Issuing time:2022/9/1 9:24:09

Sichuan Deebio Pharmaceutical Co., Ltd accepted the official GMP compliance inspection from Japan PMDA from 8.25 to 8.26 in 2022. The GMP audit team consisted of two auditors led by experienced veteran experts and carried out a two-day remote audit. The experts of the inspection team conducted a comprehensive inspection of Deebio's quality management system, production management system, on-site operation, laboratory management, related supporting facilities and equipment, and maintenance of public systems.

 

Through the inspection, the experts of the inspection team have unanimously affirmed and highly recognized Deebio's GMP quality management system. Finally, Deebio has successfully passed the official GMP certification of Japan's PMDA!


图片1.jpg


PMDA (Pharmaceuticals and Medical Devices Agency) is a Japanese agency responsible for technical review of drugs and medical devices. It is functionally similar to the FDA in the United States and the NMPA in China.


图片2.jpg


Deebio has passed the EU-GMP and Chinese GMP certification. The successful passing of Japan's PMDA certification marks a phased victory in Deebio's global strategy!


图片3.jpg



《互联网药品信息资格证书》

证书编号:(川)-非经营性-2018-0045

蜀ICP备13015778号-1  

本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息

Add.:

Concentrated Industrial Development District

of Guanghan City, Sichuan Province

Tel:

Sales :0086-838-5702999

Sales :0086-838-5703006      ( INT )

Mail:

info@deebio.com

ggone@deebio.com